LOVELAND — Heska Corp. (Nasdaq: HSKA) bought Biotech Laboratories U.S.A. LLC on Sept. 1.
BizWest's Notable Women in Human Resources recognizes outstanding women who recruit, attract and engage employees, and help manage the rapid change every business must navigate today.
We are welcoming nominations to help us determine those leaders we will recognize in the November edition of BizWest.
Heska sells veterinary diagnostic and specialty products including testing instruments, digital imaging products, software and data services, and tests and treatments for animal allergies, immunotherapy and heartworm prevention.
Rockville, Maryland-based Biotech Labs develops rapid assay diagnostic tests to detect infectious and parasitic diseases in animals. The seller of the unit was Biotech Holdings U.S.A. LLC.
Heska CEO and president Kevin Wilson said in a press release that the acquisition adds to the company’s product line and intellectual property. He said the single-use rapid assay diagnostics market globally totals about $500 million and is growing.
Heska’s TTM revenue was about $246 million. Its market cap is $2.8 billion.
© 2021 BizWest Media LLC